124 results on '"Masuya, keiichi"'
Search Results
2. 2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein
3. DLiP-PPI library: An integrated chemical database of small-to-medium-sized molecules targeting protein–protein interactions
4. A liquid-phase continuous-flow peptide synthesizer for preparing C-terminal free peptides
5. Extended Solution-phase Peptide Synthesis Strategy Using Isostearyl-Mixed Anhydride Coupling and a New C-Terminal Silyl Ester-Protecting Group for N-Methylated Cyclic Peptide Production
6. Knowledge-Based Virtual Screening: Application to the MDM4/p53 Protein–Protein Interaction
7. Isostearyl Mixed Anhydrides for the Preparation of N-Methylated Peptides Using C-Terminally Unprotected N-Methylamino Acids
8. Total synthesis of (-)-coriolin
9. In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor
10. Highly regio- and stereoselective (3+2) cyclopentanone annulation using a 3-(alkylthio)-2-siloxyallyl cationic species
11. Front Cover: Structural States of Hdm2 and HdmX: X‐ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes (ChemMedChem 14/2019)
12. Structural States of Hdm2 and HdmX: X‐ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes
13. Discovery of a novel class of highly potent inhibitors of the p53–MDM2 interaction by structure-based design starting from a conformational argument
14. Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53–MDM2 interaction with a distinct binding mode
15. Constrained Peptides in Drug Discovery and Development
16. Correction: A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097
17. Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction
18. Abstract 4855: Discovery of NVP-HDM201 - First disclosure of a Next-Generation Mdm2 inhibitor with superior characteristics
19. Abstract 1225: NVP-HDM201: cellular and in vivo profile of a novel highly potent and selective PPI inhibitor of p53-Mdm2
20. Abstract 1239: NVP-HDM201: Biochemical and biophysical profile of a novel highly potent and selective PPI inhibitor of p53-Mdm2
21. New trends in drug discovery and development by constrained peptides
22. What is the Transcendental Object? : In the Matter of the Empirical Knowledge
23. The central valine concept provides an entry in a new class of non peptide inhibitors of the p53–MDM2 interaction
24. Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors
25. A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097
26. Author response: A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097
27. Corrigendum to “Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction” [Bioorg. Med. Chem. Lett. 24 (9) (2014) 2110–2114]
28. New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck
29. Abstract 1797: Discovery of NVP-CGM097, a highly potent and optimized small molecule inhibitor of Mdm2 under evaluation in a Phase I clinical trial
30. Abstract DDT01-01: Discovery of CGM097 as a novel Mdm2 inhibitor
31. Abstract 4638: NVP-CGM097: a novel p53-Mdm2 inhibitor exhibiting potent antitumor activity in mouse models of human cancer
32. Abstract 1798: Mechanistic study of NVP-CGM097: a potent, selective and species specific inhibitor of p53-Mdm2
33. Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-Cyanopyrimidines. Part 2
34. 4-Amino-2-cyanopyrimidines: Novel scaffold for nonpeptidic cathepsin S inhibitors
35. Discovery of selective and nonpeptidic cathepsin S inhibitors
36. 経験認識における超越論的対象の意義
37. ChemInform Abstract: New Pyrazolo[1,5a]pyridimines as Orally Active Inhibitors of Lck.
38. ChemInform Abstract: A New Method for the Synthesis of Medium- and Large-Sized Carbocycles.
39. Orally Bioavailable Cathepsin K Inhibitors with Pyrrolopyrimidine Scaffold
40. Editorial [Hot topic: The Medicinal Chemistry of the Cathepsin Cysteine Proteases (Guest Editors: Keiichi Masuya and Naoki Teno)]
41. Small molecules for bone diseases
42. Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes
43. Novel scaffold for cathepsin K inhibitors
44. Effect of Cathepsin K Inhibitors on Bone Resorption
45. ChemInform Abstract: Total Synthesis of (‐)‐Coriolin.
46. A New Method for the Synthesis of Medium- and Large-Sized Carbocycles
47. Total Synthesis of (−)-Coriolin
48. Highly efficient method for coriolin synthesis
49. Diastereoselective Introduction of Carbon Chain to Pyrrolidone Derivatives
50. 3-(Alkylthio)-1,2-bis(siloxy)-3-butenes as efficient chirality transferred building blocks
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.